DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma.
Katharina FilipskiMichael SchererKim N ZeinerAndreas BucherJohannes KleemannPhilipp JurmeisterTabea I HartungMarkus MeissnerKarl H PlateTim R FentonJörn WalterSascha TierlingBastian SchillingPia S ZeinerPatrick N HarterPublished in: Journal for immunotherapy of cancer (2022)
These results demonstrate that LMC-based segregation of large-scale DNA methylation data is a promising tool for classifier development and treatment response estimation in cancer patients under targeted immunotherapy.